Obstetrics/Gynecology
RSSArticles
-
Full February 15, 2007 Issue in PDF
-
Pharmacology Watch
Several important papers have been published in the last 2 months, none more important than the realization that breast cancer rates have dropped precipitously since the publication of the Women's Health Initiative (WHI) in 2002. -
Clinical Briefs By Louis Kuritzky, MD
The most popularly used pharmacotherapy for prevention and/or treatment of osteoporosis (OSPS) is bisphosphonate (BIS), specifically alendronate and risedronate. -
Phenotypic Differences between Male Physicians, Surgeons, and Film Stars: Comparative Study
A paper just emerged in the research section of the British Medical Journal that gives new meaning to scientific investigation. -
Pharmacology Watch
Several important papers have been published in the last 2 months, none more important than the realization that breast cancer rates have dropped precipitously since the publication of the Women's Health Initiative (WHI) in 2002. -
Full February 1, 2007 Issue in PDF
-
Clinical Briefs in Primary Care Supplement
-
Secondary Osteoporosis
Osteoporosis is defined as a skeletal disorder characterized by a decline in bone strength leading to enhanced risk of fracture. -
Full March 2007 Issue in PDF
-
Trichomoniasis in men — common, often undetected
As you review the chart for your next patient, a heterosexual women seeking treatment for a yellow-green vaginal discharge and vulvar irritation, you see her test results are positive for trichomoniasis. When you discuss the test results with the patient, she tells you her partner has had no symptoms of infection.